Related Experiment Video
Updated: Sep 28, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Naloxone Metabolism Associated With Unexpected Noroxymorphone Detected in Urine During Pregnancy
Marcela C Smid1, Jasmin E Charles1, Gwendolyn A McMillin1
1Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, and Department of Pathology, University of Utah Health, Salt Lake City, Utah; and NMS Laboratories, Horsham, Pennsylvania.
Background:
Urine drug testing (UDT) is commonly used in obstetrics to monitor opioid use disorder treatment, but interpretation can be difficult and may trigger harmful consequences, including child welfare reporting. Noroxymorphone, also referred to as nornaloxone, may arise from metabolism of naloxone, oxycodone, or oxymorphone and may be detected in patients taking buprenorphine/naloxone.
Cases:
Two pregnant individuals receiving buprenorphine/naloxone had unexpected presumptive positive opiate screens. Confirmatory testing showed isolated low-level noroxymorphone (46 and 79 ng/mL) without detectable parent opioids, consistent with naloxone metabolism rather than opioid use. Both patients experienced significant distress after the initial results.
Conclusion:
Clinicians should recognize naloxone-associated noroxymorphone to avoid misclassifying return to use. Confirmatory testing and interpretation are essential to prevent harm and preserve clinician-patient trust.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Pharmaceutical Poisoning: Treatment Strategies
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Phase I Reactions: Reductive Reactions
